AIMZ Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.05M Sell
25,324
-308
-1% -$35.6K 0.94% 36
2025
Q4
$2.7M Sell
25,632
-298
-1% -$28K 0.77% 41
2025
Q3
$2.18M Sell
25,930
-403
-2% -$33.2K 0.68% 48
2025
Q2
$2.08M Sell
26,333
-565
-2% -$44.9K 0.7% 48
2025
Q1
$2.41M Buy
26,898
+298
+1% +$27.8K 0.84% 40
2024
Q4
$2.65M Sell
26,600
-199
-0.7% -$20.5K 0.92% 34
2024
Q3
$3.04M Buy
26,799
+76
+0.3% +$9.03K 1.04% 33
2024
Q2
$3.31M Sell
26,723
-720
-3% -$92.7K 1.19% 26
2024
Q1
$3.62M Sell
27,443
-849
-3% -$105K 1.35% 22
2023
Q4
$3.08M Sell
28,292
-168
-0.6% -$17.4K 1.25% 25
2023
Q3
$2.93M Sell
28,460
-99
-0.3% -$10.7K 1.3% 26
2023
Q2
$3.3M Sell
28,559
-164
-0.6% -$18.6K 1.42% 20
2023
Q1
$3.06M Sell
28,723
-649
-2% -$70.1K 1.37% 23
2022
Q4
$3.26M Sell
29,372
-228
-0.8% -$23.3K 1.54% 22
2022
Q3
$2.55M Sell
29,600
-99
-0.3% -$8.84K 1.29% 25
2022
Q2
$2.71M Sell
29,699
-249
-0.8% -$22.1K 1.3% 29
2022
Q1
$2.46M Sell
29,948
-771
-3% -$60.8K 1.01% 37
2021
Q4
$2.35M Sell
30,719
-16
-0.1% -$1.27K 0.92% 41
2021
Q3
$2.31M Sell
30,735
-473
-2% -$36K 1.04% 35
2021
Q2
$2.43M Sell
31,208
-1,130
-3% -$84K 1.09% 34
2021
Q1
$2.38M Buy
32,338
+21,928
+211% +$1.62M 1.16% 33
2020
Q4
$812K Buy
10,410
+2
+0% +$153 0.43% 61
2020
Q3
$824K Buy
10,408
+1
+0% +$78 0.49% 53
2020
Q2
$768K Buy
10,407
+1
+0% +$75 0.5% 54
2020
Q1
$764K Sell
10,406
-77
-0.7% -$6.05K 0.59% 52
2019
Q4
$910K Sell
10,483
-390
-4% -$32K 0.59% 55
2019
Q3
$873K Sell
10,873
-25
-0.2% -$2K 0.6% 56
2019
Q2
$872K Buy
10,898
+1
+0% +$77 0.6% 56
2019
Q1
$865K Sell
10,897
-418
-4% -$31.3K 0.59% 56
2018
Q4
$825K Buy
11,315
+2
+0% +$141 0.64% 55
2018
Q3
$766K Buy
11,313
+1
+0% +$64 0.49% 60
2018
Q2
$655K Buy
11,312
+1
+0% +$56 0.46% 65
2018
Q1
$588K Sell
11,311
-104
-0.9% -$5.62K 0.43% 65
2017
Q4
$613K Sell
11,415
-104
-0.9% -$5.77K 0.46% 65
2017
Q3
$704K Buy
11,519
+3
+0% +$182 0.58% 57
2017
Q2
$704K Sell
11,516
-52
-0.4% -$3.17K 0.59% 59
2017
Q1
$701K Buy
11,568
+1
+0% +$61 0.59% 60
2016
Q4
$650K Sell
11,567
-104
-0.9% -$6.09K 0.58% 58
2016
Q3
$695K Buy
11,671
+47
+0.4% +$2.75K 0.62% 56
2016
Q2
$639K Sell
11,624
-11,158
-49% -$594K 0.59% 59
2016
Q1
$1.2M Buy
22,782
+11,209
+97% +$549K 0.53% 60
2015
Q4
$583K Buy
11,573
+1
+0% +$50 0.53% 60
2015
Q3
$545K Buy
11,572
+315
+3% +$16.7K 0.5% 63
2015
Q2
$611K Buy
11,257
+50
+0.4% +$2.8K 0.53% 61
2015
Q1
$615K Buy
11,207
+734
+7% +$41.6K 0.53% 58
2014
Q4
$567K Buy
+10,473
New +$584K 0.51% 60

Other funds holding MRK

AIMZ Investment Advisors's MRK Position: Q1 2026 in Review

AIMZ Investment Advisors reduced its Merck (MRK) stake by 1.2% in Q1 2026, selling an estimated $35.6K and leaving 25,324 shares worth $3.05M. The position accounts for 0.94% of the portfolio, ranked #36.

AIMZ Investment Advisors first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. The position peaked at $3.62M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • AIMZ Investment Advisors held 25,324 shares of Merck worth $3.05M as of Q1 2026.
  • AIMZ Investment Advisors sold 308 Merck shares in Q1 2026, an estimated $35.6K.
  • Merck made up 0.94% of AIMZ Investment Advisors's portfolio in Q1 2026, its #36 holding.
  • AIMZ Investment Advisors first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
  • AIMZ Investment Advisors's Merck position peaked at $3.62M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on AIMZ Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.